Zorglim MV 2 mg/500 mg/0.3 mg Tablet
By Zorglim MV
Rx
10 Tablet in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Instanz Life Sciences Pvt Ltd
6-A B Compound, Opp. Mayuri Cinema Road, Sahar Road, Mumbai – 400069., Maharashtra, India

Expires on or after
April, 2027

liver
When using Zorglim MV 2 mg/500 mg/0.3 mg Tablet, it is important to be cautious if you have liver disease. In such cases, your doctor may need to adjust the dosage of the medication. Patients with mild to moderate liver disease usually start with a lower dose of Zorglim MV 2 mg/500 mg/0.3 mg Tablet. However, it is not advisable to use this medication if you have severe liver disease. Make sure to consult your doctor for proper guidance when considering the use of Zorglim MV 2 mg/500 mg/0.3 mg Tablet.

kidney
Zorglim MV 2 mg/500 mg/0.3 mg Tablet may not be safe for people with kidney disease. It is advised to avoid using this medication in such cases. Consulting a doctor is recommended before use.

alcohol
It is not safe to drink alcohol while taking Zorglim MV 2 mg/500 mg/0.3 mg Tablet.

driving
Caution is advised when driving if experiencing low or high blood sugar symptoms with Zorglim MV 2 mg/500 mg/0.3 mg Tablet. Refrain from driving in such cases.

pregnancy
Zorglim MV 2 mg/500 mg/0.3 mg Tablet may not be safe for use during pregnancy, as animal studies have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing it to you. Please consult your doctor.

breastfeeding
Zorglim MV 2 mg/500 mg/0.3 mg Tablet is likely unsafe during breastfeeding, as evidence indicates it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹135
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024